Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E Protein, Accession: Q9J3M8

/在： /经由过程：
  • 产物概述
  • 产物规格
  • 运输及存储
  • 品牌申明

    • 产物概述

    产物描写

    Recombinant Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E Protein is expressed from HEK293 with His tag at the C-terminal.It contains Ser31-Tyr538.

    Biotinylated

    产物规格

    靶点

    Envelope glycoprotein E

    份子又名

    Accession

    种属

    Varicella-zoster virus (strain Oka vaccine)

    卵白序列

    Ser31-Tyr538

    份子量

    The protein has a predicted MW of 58.39 kDa. Due to glycosylation, the protein migrates to 65-85 kDa based on Tris-Bis PAGE result.

    活性

    产物标签

    C-His

    抒发体系

    HEK293

    纯度

    > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产物表面

    Lyophilized

    运输前提

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和不变性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 该物质的企业品牌ChemWhat是Watson的注册申请钢材牌号，由Watson受权山东海角社区 在中国现代中国温带季风气候利用率，点此拜候。